Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Idarubicin hydrochloride 5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Idarubicin hydrochloride 1mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Idarubicin hydrochloride 1mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Idarubicin hydrochloride 1mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
|
Idarubicin hydrochloride 5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Idarubicin hydrochloride 5 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Idarubicin hydrochloride 5 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/10 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/10 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 5 milligram/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 5 milligram/5 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Idarubicin hydrochloride 1 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |
Idarubicin hydrochloride 1 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Idarubicin hydrochloride |
Inferred relationship |
Some |
1 |